Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Join | Sign in
Home>Products>Product News
  Product News
Data Presented at AACR 2015 Recognizes Value of EKF PointMan Technology
Thursday, April 23, 2015
PointMan used for non-invasive analysis for T790M mutations of EGFR.

SYGNIS Announces Global Launch of SunScript™ Reverse Transcriptase
Tuesday, April 21, 2015
Products available through international distribution partners in North America, Asia and Europe and SYGNIS online shop.

Regenerys® Announces Pilot Study of its Adiposet Service
Tuesday, April 21, 2015
Study of Adiposet tissue collection, testing and storage service for lipomodelling that will provide safety, confidence and affordability.

New Nucleic Acid and Protein Purification System Helps Ensure Efficient, Reliable Purification
Tuesday, April 21, 2015
Advanced functionality designed to improve reproducibility, deliver high quality samples with less time and effort.

Accurate Detection of Fusion Transcripts
Tuesday, April 21, 2015
New TaqMan gene expression research assays designed to enable accurate detection of fusion transcripts using real-time PCR.

Medical University of Vienna Research Demonstrates Value of ANGLE plc’s ‘Blood Biopsy’ Technology
Tuesday, April 21, 2015
Poster presentation at AACR April 21 shows Parsortix™ system in capturing and analyzing mRNA of circulating tumor cells for ovarian and breast cancer.

New GeneChip® WT Pico Kit Prepares Array Target from Picogram Amounts of RNA
Monday, April 20, 2015
Kit for Affymetrix GeneChip Whole-Transcriptome Arrays enables expression analysis from as few as 10 cells.

New Affymetrix Software Helps Identify Cancer Driver Events
Monday, April 20, 2015
Software program combines whole-genome copy-number data with gene expression profiles to reveal functional impacts.

Selvita to Release the Most Recent Results from its Oncology Programs
Saturday, April 18, 2015
Company will publish the most recent data at the upcoming AACR Annual Meeting 2015.

<< 1 2 3 4 5 6 7 >>
Showing Results 31 - 40 of 2568
Scientific News
Personalized Screening for Ovarian Cancer
With 60% of women diagnosed with ovarian cancer dying within five years of diagnosis there has been considerable efforts to try to detect the disease at an earlier stage.
Gene Therapy for Cystic Fibrosis Shows Encouraging Trial Results
A therapy that replaces the faulty gene responsible for cystic fibrosis in patients' lungs has produced encouraging results in a major UK trial.
In Blinding Eye Disease, Trash-Collecting Cells Go Awry, Accelerate Damage
NIH research points to microglia as potential therapeutic target in retinitis pigmentosa.
How the Mammoth Got its Wool
Evolutionary change in a gene reconstructed in the lab from the woolly mammoth was part of a suite of adaptations that allowed the mammoth to survive in harsh arctic environments, according to new research.
Brain Cells Switch Epigenetic Gears Throughout Life
Research finds that histone turnover regulates how genes in the brain are turned on and off in response to various stimuli, thereby allowing neurons to form new synaptic connections.
More Accurate Prediction on Prognosis in Multiple Myeloma (Bone Marrow Cancer)
Test of Dutch-based SkylineDx gives patients better insight in their chances and enables clinicians to adjust their treatment.
NuGEN Scientists Screen 400+ Genes for Fusion Events in Single Assay
Breakthrough proves efficacy of new sample preparation method that could accelerate cancer research and development of treatments and diagnostic tests.
Team Identifies Gene Responsible for Some Cases of Male Infertility
In the most severe form of male infertility, men do not make any measurable levels of sperm. This condition, called azoospermia, affects approximately 1 percent of the male population and is responsible for about a sixth of cases of male infertility.
Potential Therapeutic for Blinding Eye Disease
NIH research points to microglia as potential therapeutic target in retinitis pigmentosa.
Animals’ Genomic Buffers May Help Humans
Researchers at Duke University School of Medicine and Brigham and Women’s Hospital, Harvard Medical School have identified a mechanism that explains why some mutations can be disease-causing in one genome but benign in another.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters